Dietary modulation of mammary tumorigenesis in the PymT model

Information

  • Research Project
  • 8223167
  • ApplicationId
    8223167
  • Core Project Number
    R21CA158560
  • Full Project Number
    5R21CA158560-02
  • Serial Number
    158560
  • FOA Number
    PA-10-088
  • Sub Project Id
  • Project Start Date
    2/7/2011 - 13 years ago
  • Project End Date
    10/31/2012 - 11 years ago
  • Program Officer Name
    ROSS, SHARON A.
  • Budget Start Date
    2/1/2012 - 12 years ago
  • Budget End Date
    10/31/2012 - 11 years ago
  • Fiscal Year
    2012
  • Support Year
    02
  • Suffix
  • Award Notice Date
    3/20/2012 - 12 years ago

Dietary modulation of mammary tumorigenesis in the PymT model

DESCRIPTION (provided by applicant): This application has two goals: 1) to determine how a western style diet (WSD), high in fat and low in Ca and vitamin D3, affects the progression of breast cancer in the PyMT model and 2) to establish whether dietary supplementation with vitamin D3, antibody based neutralization of IL12, or genetic ablation of macrophages, can avert the protumorigenic effects of the WSD. Together, these data will determine how macrophages and macrophage- derived factors contribute to the effects of WSD. The rationale for these experiments is derived from the following facts: First, obesity associated inflammation confers increased risk for several cancers, including breast cancer. Second, it has been established that WSD stimulates hyperproliferation in the terminal end buds of the mouse mammary gland, a cancer-prone region, and that supplementing the WSD with vitamin D3 and Ca markedly suppressed the diet induced hyperproliferation. Third, we found that levels of IL-12, a macrophage-derived cytokine overexpressed in breast cancer, were highly elevated in the serum of mice fed the WSD, and returned to basal levels when WSD was supplemented with calcium and vitamin D3 (Preliminary data). This is of great significance since we recently demonstrated that vitamin D3 interrupts the IL-12 driven cross-talk between macrophages and epithelial cells and our collaborators (Lin and Pollard) established that progression of mammary tumors in the PymT model requires the presence of macrophages. Thus, our hypothesis is that due to the proinflammatory nature of WSD, such a diet will be tumor promoting. We predict that WSD alters the activity of macrophages and therefore has a profound effect on tumor progression in the PymT model of mammary tumorigenesis. We will use three strategies to avert the harmful effects of WSD. 1. We will treat mice with a novel neutralizing anti-IL-12 antibody (provided by Novartis) to determine whether neutralization of IL-12 prevents basal and WSD-induced tumor progression; 2. Based on our findings that vitamin D3, a potent chemopreventive agent, prevents the release of IL-1 from tumor associated macrophages, and that the WSD induced increases in circulating IL-12 are reversed by vitamin D3 (Preliminary data), we will determine whether vitamin D3 abrogates the tumor promoting effects of the WSD. 3. As we hypothesize that the WSD promotes mammary tumorigenesis through stimulation of macrophage-derived factors, we will determine whether the protumorigenic activities of WSD are reduced by genetic ablation of CSF1 in the PymT mice, which results in relative absence of mature macrophages. The data will provide fundamental insight into the mechanisms whereby diet high in fat and low in Ca and vitamin D3 increases the risk of breast cancer and will establish whether nutritional, anti- cytokine, or genetically mediated interruption of a specific cross talk between macrophages and mammary epithelial cells can prevent the harmful effects of WSD on mammary tumorigenesis. PUBLIC HEALTH RELEVANCE: Numerous epidemiological studies have shown that high fat diet and obesity confer increased risk for invasive breast cancer in postmenopausal women and also constitute a poor prognostic factor in breast cancer. The mechanisms whereby obesity promotes tumor progression remain poorly understood, but it appears that a low grade inflammation that is associated with obesity plays a crucial role. Indeed, we showed that a diet high in fat and low in vitamin D and Ca elevates several proinflammatory cytokines that have a potential to promote tumor growth and to regulate metastatic spread to distal organs. Interleukin 12, a proinflammatory cytokine secreted primarily by monocytes and macrophages, appears to be the main soluble factor that mediates the interaction of tumor cells with macrophages, which contribute to metastasis. The levels of IL1 are significantly increased in breast cancer and correlate with invasive ability of tumors. Our observation that vitamin D can block IL1 release suggest that this readily available chemopreventive agent could be used for preventive as well as therapeutic purposes in breast cancer and could avert the harmful, protumorigenic effects of western style diet. Consistent with this notion, a fracture risk prevention trial showed that the 4-year incidence of all cancers was reduced in US women who received high supplemental doses of both calcium and vitamin D.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R21
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
    58750
  • Indirect Cost Amount
    24088
  • Total Cost
    82838
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    393
  • Ed Inst. Type
  • Funding ICs
    NCI:82838\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    CDP
  • Study Section Name
    Chemo/Dietary Prevention Study Section
  • Organization Name
    MONTEFIORE MEDICAL CENTER (BRONX, NY)
  • Organization Department
  • Organization DUNS
    041581026
  • Organization City
    NEW YORK
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    104672490
  • Organization District
    UNITED STATES